Financially Strong Value – Page 2

#25

Aurinia Pharmaceuticals Inc (AUPH)

Healthcare · Biotechnology

Why #25: Financial quality metrics determine display order where present; otherwise companies receive a stable name/ID tie-breaker. Reported metric: Excellent. i

AUPH

NASDAQ

Excellent

7

10.50

9.70

2.6%

56.3%

$2.17B

#26

Arbutus Biopharma Corp (ABUS)

Healthcare · Biotechnology

Why #26: Financial quality metrics determine display order where present; otherwise companies receive a stable name/ID tie-breaker. Reported metric: Great. i

ABUS

NASDAQ

Great

7

28.90

-1,000.00

0.4%

-16.1%

$723.10M

#27

Zevra Therapeutics Inc (ZVRA)

Healthcare · Pharmaceuticals

Why #27: Financial quality metrics determine display order where present; otherwise companies receive a stable name/ID tie-breaker. Reported metric: Excellent. i

ZVRA

NASDAQ

Excellent

7

5.40

-0.92

0.2%

51.1%

$627.80M

#28

Compugen Ltd (CGEN)

Healthcare · Biotechnology

Why #28: Financial quality metrics determine display order where present; otherwise companies receive a stable name/ID tie-breaker. Reported metric: Excellent. i

CGEN

NASDAQ

Excellent

8

0.60

—

1.5%

79.9%

$182.80M

#29

Caledonia Mining Corporation (CMCL)

Materials · Metals & Mining

Why #29: Financial quality metrics determine display order where present; otherwise companies receive a stable name/ID tie-breaker. Reported metric: Great. i

CMCL

NYSE

Great

7

8.30

8.53

21.4%

77.0%

$410.50M

#30

Vox Royalty Corp (VOXR)

Materials · Metals & Mining

Why #30: Financial quality metrics determine display order where present; otherwise companies receive a stable name/ID tie-breaker. Reported metric: Excellent. i

VOXR

NASDAQ

Excellent

7

21.20

10.76

0.0%

44.4%

$341.70M